Schizophrenia Today is a collection of papers presenting conflicting viewpoints on schizophrenia and some focal subjects for future research. The book deals with the definition of schizophrenia and presents various advances in understanding the condition. The text surveys the problems of epidemiology and symptomatology in terms of the etiology and pathogenesis of schizophrenia. Several papers present the societal and cultural aspects of the problem on issues of clinical overview; international collaboration in schizophrenia research; and the societal determinants of schizophrenic behavior. Other papers then discuss the genetic and biochemical approaches in dealing with schizophrenia. One paper concludes that genetic factors play a significant role in the etiology of schizophrenia. The text also reviews the studies conducted by Rolf Gjessing, establishing that mood changes in mental state are related to changes in autonomic activity, metabolic rate, and nitrogen balance. The book also discusses the pharmacological and psychotherapeutic approaches in treating the problem. One paper deals with the personal experience of the writer in using psychoanalysis for treating schizophrenia. The collection will prove valuable for psychiatrists, psychologists, psychoanalysts, and students and researchers dealing with mental diseases.
Inhaltsverzeichnis
1;Front Cover;1 2;Schizophrenia Today;4 3;Copyright Page;5 4;Table of Contents;6 5;List of Participants;8 6;Poster Exhibition;14 7;Foreword;15 8;Opening Address;16 9;SESSION 1: Societal and Cultural Aspects;18 9.1;Chapter 1. Definition, Classification and Nomenclature: A Clinical Overview;20 9.1.1;References;28 9.2;Chapter 2. International Collaboration in Schizophrenia Research;30 9.2.1;Collaboration in Schizophrenia Research;31 9.2.2;The Need for a Common Language;31 9.2.3;The International Pilot Study of Schizophrenia (IPSS);32 9.2.4;Directions of Future Work;36 9.2.5;References;38 9.3;Chapter 3. Societal Determinants of Schizophrenic Behaviour;40 9.3.1;Schizophrenic Behavior;40 9.3.2;Societal Variables Influencing Behavior;41 9.3.3;Social Change: Migration;49 9.3.4;Psychosocial Events Correlated with the Occurrence of Schizophrenic Behavior;52 9.3.5;Integration: Society, Events, Behavior;57 9.3.6;Summary;61 9.3.7;References;63 10;SECTION 2: Genetic and Biochemical Approaches;66 10.1;Chapter 4. The Contribution of Genetics and Biochemistry: Chairman's Opening Remarks;68 10.1.1;References;72 10.2;Chapter 5. Genetics in Schizophrenia;74 10.2.1;Historical Review of the Genetic Hypothesis;74 10.2.2;Unity or Diversity of the Schizophrenic Syndromes;78 10.2.3;Mode of inheritance;79 10.2.4;Nature of the Principal Factors;82 10.2.5;Summary;83 10.2.6;References;84 10.3;Chapter 6. The Impact of Biochemistry on the Problem of Schizophrenia;88 10.3.1;1. The Neurological Basis of the Symptoms;88 10.3.2;2. Toxic Metabolite Hypotheses;89 10.3.3;3. Blood Proteins;91 10.3.4;4. Genetic Predisposition;91 10.3.5;5. Environmental Factors;93 10.3.6;6. The Focus of Disturbance in Schizophrenia;94 10.3.7;7. Central Transmitter Mechanisms in Schizophrenia;96 10.3.8;8. Periodic Catatonia;97 10.3.9;References;99 11;SESSION 3: Pharmacological Approaches;102 11.1;Chapter 7. Introductory Remarks;104 11.2;Chapter 8. The Impact of Pharmacology on the Problem of Schizophrenia;106 11.2.1;Introduc
tion;106 11.2.2;Discovery of Dopamine, an Endogenous Agonist in the Brain;106 11.2.3;Brain Monoamines: Neurohumoral Transmitters;107 11.2.4;Receptor-Blocking Antipsychotic Agents;107 11.2.5;Role of Different Dopaminergic Pathways;110 11.2.6;Antipsychotic Action of a Tyrosine Hydroxylase Inhibitor;111 11.2.7;The Nature of Antipsychotic Drug Effect;113 11.2.8;Amphetamines and Schizophrenia;115 11.2.9;The Possible Role of GABA in Schizophrenia;115 11.2.10;Concluding Remarks;117 11.2.11;References;118 11.3;Chapter 9. Drug-induced Psychoses and their Relationship to Schizophrenia;122 11.3.1;Introduction;122 11.3.2;I. Psychotomimetic Drugs (Hallucinogens);124 11.3.3;II. Amphetamines and Related Substances;133 11.3.4;III. Ethyl Alcohol;136 11.3.5;IV. Miscellaneous Drugs;138 11.3.6;References;143 11.4;Chapter 10. On the Biochemistry and Pharmacology of Hallucinogens;152 11.4.1;Central 5-HT neurons;153 11.4.2;Effects on Central DA Neurons;166 11.4.3;Summary;171 11.4.4;Acknowledgements;172 11.4.5;References;173 12;SESSION 4: Neuroleptic Drugs;176 12.1;Chapter 11. The Drug Approach to Therapy. Treatment of Acute Schizophrenia;178 12.1.1;I. Guides to Classification;178 12.1.2;II. Assessment and Treatment;180 12.1.3;III. Prognostic Aspects;184 12.1.4;References;186 12.2;Chapter 12. The Drug Approach to Therapy. Long-term Treatment of Schizophrenia;190 12.2.1;Etiology of Schizophrenia;190 12.2.2;Classification of Antipsychotic Drugs;190 12.2.3;General Rules for Long-term Treatment;193 12.2.4;Antiparkinsonian Treatment;193 12.2.5;Tardive Dyskinesia in Relation to Long-term Treatment;194 12.2.6;Results of Treatment;195 12.2.7;New Drugs and Drugs of the Future;196 12.2.8;Discussion;197 12.2.9;References;198 12.3;Chapter 13. Neuroleptic Drugs. Chemical versus Biochemical Classification;200 12.3.1;1. Chemical Classification;200 12.3.2;2. Biochemical Classification;209 12.3.3;3. Relation Between Chemical and Biochemical Classification;214 12.3.4;4. Summary;214 12.3.5;Acknowledgement;21
5 12.3.6;References;216 13;SESSION 5: Physiological and Psychological Findings;218 13.1;Chapter 14. Novel Neurophysiological Findings in Schizophrenia;220 13.1.1;I. Introduction;220 13.1.2;II. EEG in Adult Schizophrenics;220 13.1.3;III. Computer EEG in Schizophrenic Children;222 13.1.4;IV. CEEG Finding in Children at "high risk" for Schizophrenia;222 13.1.5;V. Summary and Conclusion;225 13.1.6;References;227 13.2;Chapter 15. Basic Logico-mathematical Structures in Schizophrenia;228 13.2.1;I. Types of Symptoms in Schizophrenia;228 13.2.2;II. Manifestations of Schizophrenia Viewed in the Light of Symbolic Logic;228 13.2.3;III. Subsequent Studies. The Two Modes of Being and the Bi-logical Structures;240 13.2.4;IV. Schizophrenic Bi-logical Structures;247 13.2.5;References;250 14;SESSION 6: Psychotherapeutic Approaches;252 14.1;Chapter 16. Some Aspects of Cognitive Activities in Schizophrenics;254 14.1.1;Methods;255 14.1.2;Results;255 14.1.3;References;261 14.2;Chapter 17. The Psychotherapeutic Approach to Schizophrenia;262 14.2.1;Historical Review of the Theoretical Bases of the Main Methods;263 14.2.2;Psychotherapy of Schizophrenia in Practice;266 14.2.3;The Acquisition of Insight;267 14.2.4;Interpretations Concerning the Formal Mechanisms;268 14.2.5;Psychodynamic Analysis;270 14.2.6;References;273 14.3;Chapter 18. The Treatment of Psychotic States, Particularly Schizophrenia, by Psychoanalysis;276 14.3.1;Notes on my Experiences with Psychotherapy and Psychoanalysis of Psychotic Patients;277 14.3.2;Comparisons Between Different Psychoanalytic Approaches;279 14.3.3;Some Recent Investigation of the Narcissistic Delusional Structures in Schizophrenia;280 14.3.4;References;285 15;SESSION 7: Synthesis and Concluding Remarks;288 15.1;Chapter 19. Recent Contributions from the basic Biological Sciences toward an understanding of Schizophrenia;290 15.2;Chapter 20. Clinical Sciences;292 16;Index;296